Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-20,811
Closed -$4.62M 972
2022
Q1
$4.62M Buy
+20,811
New +$4.5M 1.3% 10
2021
Q4
Sell
-24,321
Closed -$5.42M 1024
2021
Q3
$5.42M Buy
24,321
+1,128
+5% +$265K 1.3% 8
2021
Q2
$5.62M Buy
23,193
+68
+0.3% +$15.5K 1.27% 9
2021
Q1
$4.9M Buy
23,125
+107
+0.5% +$22.5K 1.4% 13
2020
Q4
$5.03M Sell
23,018
-2,174
-9% -$445K 1.48% 10
2020
Q3
$5.04M Buy
25,192
+916
+4% +$183K 1.46% 16
2020
Q2
$4.69M Sell
24,276
-4,121
-15% -$753K 1.25% 18
2020
Q1
$4.58M Buy
28,397
+3,390
+14% +$639K 1.28% 18
2019
Q4
$5M Buy
25,007
+5,093
+26% +$918K 0.93% 22
2019
Q3
$3.42M Buy
19,914
+1,041
+6% +$185K 0.61% 40
2019
Q2
$3.27M Buy
18,873
+6,899
+58% +$1.13M 0.57% 56
2019
Q1
$1.87M Buy
11,974
+2,579
+27% +$372K 0.37% 73
2018
Q4
$1.24M Buy
9,395
+3,559
+61% +$492K 0.22% 107
2018
Q3
$876K Buy
5,836
+951
+19% +$135K 0.16% 117
2018
Q2
$647K Sell
4,885
-1,280
-21% -$165K 0.11% 158
2018
Q1
$721K Sell
6,165
-11,824
-66% -$1.43M 0.14% 143
2017
Q4
$2.05M Sell
17,989
-16,142
-47% -$1.78M 0.35% 48
2017
Q3
$3.59M Buy
34,131
+29,691
+669% +$3.01M 0.67% 27
2017
Q2
$416K Sell
4,440
-3
-0.1% -$278 0.09% 149
2017
Q1
$395K Sell
4,443
-2,957
-40% -$254K 0.09% 146
2016
Q4
$577K Buy
7,400
+1,019
+16% +$81.9K 0.11% 142
2016
Q3
$528K Buy
6,381
+275
+5% +$22K 0.08% 151
2016
Q2
$453K Sell
6,106
-3,264
-35% -$256K 0.07% 134
2016
Q1
$717K Buy
9,370
+3,634
+63% +$264K 0.1% 112
2015
Q4
$445K Buy
5,736
+533
+10% +$41.3K 0.06% 123
2015
Q3
$362K Sell
5,203
-882
-14% -$63K 0.05% 143
2015
Q2
$409K Buy
6,085
+1,889
+45% +$128K 0.04% 155
2015
Q1
$274K Buy
+4,196
New +$277K 0.03% 182

Other funds holding V

Exane Derivatives's V Position: Q2 2022 in Review

Exane Derivatives sold out of Visa (V) in Q2 2022, closing a stake of 20,811 shares — an estimated $4.62M sold.

Exane Derivatives first reported a position in V in Q1 2015 and held it in 28 quarters. The position peaked at $5.62M in Q2 2021. 3,237 funds tracked by Wall St. Rank hold V as of Q2 2022.

  • Exane Derivatives reported no remaining Visa position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 20,811 Visa shares in Q2 2022, an estimated $4.62M.
  • Exane Derivatives first reported a position in Visa in Q1 2015 and held it in 28 quarters.
  • Exane Derivatives's Visa position peaked at $5.62M in Q2 2021.
  • 3,237 funds tracked by Wall St. Rank held Visa as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.